Multimodality local consolidative treatment versus conventional care of advanced lung cancer after first-line systemic anti-cancer treatment: study protocol for the RAMON multicentre randomised controlled trial with an internal pilot
Introduction Lung cancer is the most common cause of cancer death worldwide and most patients present with extensive disease. One-year survival is improving but remains low (37%) despite novel systemic anti-cancer treatments forming the current standard of care. Although new therapies improve surviv...
Saved in:
| Main Authors: | Matthew Evison, Tim Batchelor, Chris A Rogers, Sarah Baos, Elizabeth A Stokes, Rosie Harris, Eric Lim, Chloe Beard, Janette Rawlinson, Nicola Mills, John Conibear, Paulo De Sousa, Thomas Newsom-Davis, Tara Barwick, Leah Fleming |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMJ Publishing Group
2023-12-01
|
| Series: | BMJ Open |
| Online Access: | https://bmjopen.bmj.com/content/13/12/e081650.full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
How representative are colorectal, lung, breast and prostate cancer patients responding to the National Cancer Patient Experience Survey (CPES) of the cancer registry population in England? A population-based case control study
by: Margreet Lüchtenborg, et al.
Published: (2019-12-01) -
In memoriam: Prof° Ramón Carrilo
by: Raul F. Matera
Published: (1958-03-01) -
Local consolidative therapy in oligometastatic non-small-cell lung cancer after effective systemic treatment: who will benefit?
by: Jiayi Deng, et al.
Published: (2025-01-01) -
Entrevista con Ramón León Donayre
by: Allison Manrique Mattos, et al.
Published: (2018-12-01) -
Pérez Mantilla, Ramón. Textos reunidos
by: Germán Meléndez
Published: (2012-09-01)